Marchex (NASDAQ:MCHX) said it is seeing improving momentum from new artificial intelligence-driven products and operating efficiencies as management outlined first-quarter 2026 results, updated adjusted EBITDA guidance and details on its proposed acquisition of Archenia, Inc.
On the company’s earni
Marchex reports Q3 2025 results, missing revenue but meeting profit targets. The stock rose on news of its strategic Archenia acquisition and a positive 2026 growth outlook.
Marchex posted mixed Q2 2025 results with revenue missing estimates but adjusted EBITDA and EPS improving. AI-driven growth and new partnerships signal future potential despite short-term challenges.
